Please assess the completion status of the following clinical trial:

Trial Title: Valchlor in the Treatment of Lichen Planopilaris

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Male and female patients 18 years or older.~* Biopsy proven diagnosis of Lichen Planopilaris~* Biopsy proven diagnosis of Fontal Fibrosing Alopecia (a clinical variant of LPP restricted to frontal scalp)~* Good general health as confirmed by medical history~* Patients who are willing and capable of cooperating to the extent and degree required by the protocol; and~* Patients who read and sign an approved informed consent for this study~Exclusion Criteria:~* Vulnerable study population~* Pregnant or nursing women~* Women planning a pregnancy within the study period~* Active smokers~* Known history of adverse reaction to mechlorethamine~* Use of systemic immunosuppressive~* Presence of ulcerated scalp lesions

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Valchor treatment of Lichen Planopilaris (Type: EXPERIMENTAL): Once daily application of Valchlor in decreasing disease activity in patients with Lichen Planopilaris.

Based on this trial design, predict the completion outcome and termination type (if applicable).